EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.1168
March 31, 2026 -0.1316
December 31, 2025 -0.1213
September 30, 2025 -0.1393
June 30, 2025 -0.2443
March 31, 2025 -0.2688
December 31, 2024 -0.3674
September 30, 2024 -0.328
June 30, 2024 -0.4243
March 31, 2024 -0.3659
December 31, 2023 -0.4112
September 30, 2023 -0.6484
June 30, 2023 -0.5026
March 31, 2023 -0.4883
Date Value
December 31, 2022 -0.5994
September 30, 2022 -0.5812
June 30, 2022 -0.6458
March 31, 2022 -0.5791
December 31, 2021 0.1754
September 30, 2021 -0.413
June 30, 2021 -0.5631
March 31, 2021 -0.2828
December 31, 2020 -0.2876
September 30, 2020 -0.2834
June 30, 2020 -0.1487
March 31, 2020 -0.1569
December 31, 2019 -0.1765
September 30, 2019 -0.1744

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.1822
Alnylam Pharmaceuticals, Inc. 1.207
Savara, Inc. -0.1587
Vericel Corp. 0.0422
Biogen, Inc. 0.6557

EPS Diluted (Quarterly) Related Metrics